CARISMA Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3675 Market St Ste 200, Philadelphia, Pe...Phone Number
(267) 491-6422Website
www.carismatx.comRevenue
$10.8 MillionStock Symbol
CARMIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About CARISMA Therapeutics
Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA.Explore more
CARISMA Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CARISMA Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CARISMA Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CARISMA Therapeutics
Funding: Get notified immidiatlly once CARISMA Therapeutics has new funding data
CARISMA Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if CARISMA Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CARISMA Therapeutics launches new products
Check out if CARISMA Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CARISMA Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined CARISMA Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to CARISMA Therapeutics
Compare insights from companies similar to CARISMA Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CARISMA Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CARISMA Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CARISMA Therapeutics.
CARISMA Therapeutics financials insights
Gather financial insights about CARISMA Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$53M
2021
Series B
$59M
CARISMA Therapeutics Tech Stack
A closer look at the technologies used by CARISMA Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CARISMA Therapeutics
Sign Up For FreeTo access detailed company insights
Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylva... Read More
